Science Explorer Back to mapMap
Discussion
Company · Covington · United States

Bexion Pharmaceuticals (United States)

bexionpharma.comROR OpenAlex
Research works
18
▲ 200% vs 2018-21
Citations
37
2.1 per fractional work
Top-10% rate
7.7%
all institutions 10.0%
Open access
43%
world 40%
International
11%
world 18%
Bexion Pharmaceuticals (United States)

Not ranked overall: Bexion Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Bexion Pharmaceuticals (United States) work in?

In all years, 47% of research at Bexion Pharmaceuticals (United States) is in Life Sciences, 42% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (42%), Medicine (42%), Materials Science (4%). It does 2.0× the world's share of Life Sciences.

Life Sciences: 8 fractional works · 46.9% of its workBiochemistry, Genetics and Molecular Biology: 7 fractional works · 41.9% of its workMolecular Biology: 5 fractional works · 29.3% of its workCell Biology: 1 fractional works · 6.3% of its workCancer Research: 1 fractional works · 4.0% of its workBiotechnology: 0 fractional works · 2.2% of its workImmunology and Microbiology: 1 fractional works · 3.6% of its workImmunology: 1 fractional works · 3.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.4% of its workDrug Discovery: 0 fractional works · 1.0% of its workPharmaceutical Science: 0 fractional works · 0.5% of its workHealth Sciences: 7 fractional works · 41.9% of its workMedicine: 7 fractional works · 41.8% of its workOncology: 2 fractional works · 8.8% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 6.7% of its workEpidemiology: 1 fractional works · 5.9% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 5.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 2.9% of its workPhysiology: 0 fractional works · 2.5% of its workNeurology: 0 fractional works · 2.2% of its workPharmacology: 0 fractional works · 1.9% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.3% of its workBiochemistry: 0 fractional works · 1.0% of its workComplementary and alternative medicine: 0 fractional works · 0.6% of its workGenetics: 0 fractional works · 0.6% of its workInfectious Diseases: 0 fractional works · 0.6% of its workGastroenterology: 0 fractional works · 0.5% of its workSurgery: 0 fractional works · 0.5% of its workHepatology: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.2% of its workPhysical Sciences: 1 fractional works · 6.9% of its workMaterials Science: 1 fractional works · 4.1% of its workBiomaterials: 1 fractional works · 4.1% of its workEngineering: 0 fractional works · 2.6% of its workBiomedical Engineering: 0 fractional works · 2.6% of its workEnvironmental Science: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 4.3% of its workBusiness, Management and Accounting: 0 fractional works · 2.9% of its workManagement Information Systems: 0 fractional works · 2.9% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.4% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workFinance: 0 fractional works · 0.5% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workALL ITS WORKBexionPharmaceuticals…18fractional works, all years
Life Sciences47%Physical Sciences7%Health Sciences42%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology741.9%
    2. Immunology and Microbiology13.6%
    3. Pharmacology, Toxicology and Pharmaceutics01.4%
    1. Medicine741.8%
    2. Veterinary00.2%
    1. Materials Science14.1%
    2. Engineering02.6%
    3. Environmental Science00.2%
    1. Business, Management and Accounting02.9%
    2. Economics, Econometrics and Finance01.4%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 6.42× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 3.14× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 5.50× its world share, 0 worksPharmacology, Toxico…Engineering: 0.23× its world share, 0 worksEngineeringEnvironmental Science: 0.05× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.92× its world share, 0 worksMaterials ScienceMedicine: 2.78× its world share, 7 worksMedicineVeterinary: 1.71× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.4×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology6.42×4 works
  2. Pharmacology, Toxicology and Pharmaceutics5.50×0 works
  3. Immunology and Microbiology3.14×0 works
  4. Medicine2.78×7 works
  5. Veterinary1.71×0 works
  6. Materials Science0.92×0 works
  7. Engineering0.23×0 works
  8. Environmental Science0.05×0 works

Who are the top researchers at Bexion Pharmaceuticals (United States)?

Ranked on the quality score, Tariq Arshad and Michael Gazda lead among researchers whose main affiliation is Bexion Pharmaceuticals (United States).

  1. 1 Tariq Arshad United States · #1,578,159 worldwide 325 citations · 40 works
  2. 2 Michael Gazda United States · #3,216,271 worldwide 26 citations · 17 works
All ranked researchers at Bexion Pharmaceuticals (United States)

What are the most cited papers from Bexion Pharmaceuticals (United States)?

The most cited paper from Bexion Pharmaceuticals (United States) is "Prevalence of Helicobacter Pylori in Asymptomatic Population a Pilot Serological Study in Bangladesh" (Mian Mashhud Ahmad, Mahbubur Rahman, Azharul Karim Rumi et al., 1997), with 89 citations. Next come "Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine" (18) and "Model nematodes as a practical innovation to promote high throughput screening of natural products for anthelmintics discovery in South Asia: Current challenges, proposed practical and conceptual solutions" (8).

Most cited papers
#PaperReleasedCitations
1 Prevalence of Helicobacter Pylori in Asymptomatic Population a Pilot Serological Study in Bangladesh Mian Mashhud Ahmad, Mahbubur Rahman, Azharul Karim Rumi et al. · Journal of Epidemiology Open access 1997 89
2 Imaging of brain tumors with paramagnetic vesicles targeted to phosphatidylserine Patrick M. Winter, John Pearce, Zhengtao Chu et al. · Journal of Magnetic Resonance Imaging Open access 6 May 2014 18
3 Model nematodes as a practical innovation to promote high throughput screening of natural products for anthelmintics discovery in South Asia: Current challenges, proposed practical and conceptual solutions Muntasir Kamal, Suprabhat Mukherjee, Bishnu P. Joshi et al. · Molecular and Biochemical Parasitology 18 Sep 2023 8
4 An Assessment to Identify Causes of ERP Implementation Failure and to Predict Its Success: A Case Study on Beximco Pharmaceuticals Limited Mohammad Anisur Rahman, Bijeta Saha · SSRN Electronic Journal PreprintOpen access 2016 6
5 A First-in-Human Phase I Study of BXQ-350, a First-in-Class Sphingolipid Metabolism Regulator, in Patients with Advanced/Recurrent Solid Tumors or High-Grade Gliomas Olivier Rixe, John Lee Villano, Robert Wesolowski et al. · Clinical Cancer Research Open access 12 Sep 2024 5
All 15 most cited papers, with filters and sorting

Which research topics does Bexion Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Sphingolipid Metabolism and Signaling, Natural Antidiabetic Agents Studies, Autophagy in Disease and Therapy and Cancer Treatment and Pharmacology.

Sphingolipid Metabolism …2Sphingolipid Metabolism and Signaling: 2 fractional worksNatural Antidiabetic Age…1Natural Antidiabetic Agents Studies: 1 fractional worksAutophagy in Disease and…1Autophagy in Disease and Therapy: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksRadiomics and Machine Learning in Medical Imaging: 0 fractional worksBlood Pressure and Hypertension Studies: 0 fractional worksNanoplatforms for cancer theranostics: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional works
Molecular BiologyEndocrinology, Diabetes and MetabolismEpidemiologyOncology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sphingolipid Metabolism and Signaling Molecular Biology 2 works
  2. 2 Natural Antidiabetic Agents Studies Endocrinology, Diabetes and Metabolism 1 works
  3. 3 Autophagy in Disease and Therapy Epidemiology 1 works
  4. 4 Cancer Treatment and Pharmacology Oncology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
  8. 8 Blood Pressure and Hypertension Studies Cardiology and Cardiovascular Medicine 0 works
  9. 9 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  10. 10 Cancer, Hypoxia, and Metabolism Cancer Research 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available43.2%not open56.8%

World: 40% of research is openly available.

with international co-authors10.9%domestic only89.1%

World: 18% is written across borders.

How has Bexion Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 200% higher than in 2018-2021.

still counting200020052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Covington

All research institutions in Covington

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Bexion Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.